| Share Name |
Share Symbol |
Market |
Type |
Share ISIN |
Share Description |
| Epe Special Opportunities Limited |
LSE:ESO |
London |
Ordinary Share |
BMG3163K1053 |
ORD 5P (DI) |
| |
Price Change |
% Change |
Share Price |
Shares Traded |
Last Trade |
| |
5.00 |
3.12% |
165.00 |
28,389 |
15:33:55 |
| Bid Price |
Offer Price |
High Price |
Low Price |
Open Price |
|
155.00
|
175.00
|
165.00 |
160.00 |
160.00 |
| Industry Sector |
Turnover (m) |
Profit (m) |
EPS - Basic |
PE Ratio |
Market Cap (m) |
|
Equity Investment Instruments
|
0.10
|
-3.34
|
-10.42
|
|
49
|
| Last Trade Time |
Trade Type |
Trade Size |
Trade Price |
Currency |
| 17:06:47 |
O |
16,000 |
165.00 |
GBX |
Epe Special Opportunities News
| Trade Time |
Trade Price |
Trade Size |
Trade Value |
Trade Type |
| 16:06:47 | 165.00 | 16,000 | 26,400.00 | O |
| 12:34:40 | 175.00 | 10,000 | 17,500.00 | O |
| 08:14:45 | 173.00 | 389 | 672.97 | O |
| 07:57:18 | 170.00 | 1,000 | 1,700.00 | O |
| 07:35:33 | 170.00 | 1,000 | 1,700.00 | O |
| Date | Subject |
|---|
04/6/2020
09:20 | Epe Special Opportunities Daily Update: Epe Special Opportunities Limited is listed in the Equity Investment Instruments sector of the London Stock Exchange with ticker ESO. The last closing price for Epe Special Opportunities was 160p.
Epe Special Opportunities Limited has a 4 week average price of 160p and a 12 week average price of 127.50p.
The 1 year high share price is 210p while the 1 year low share price is currently 127.50p.
There are currently 29,511,237 shares in issue and the average daily traded volume is 5,396 shares. The market capitalisation of Epe Special Opportunities Limited is £48,693,541.05.
|
28/12/2017
07:26 | spectoacc: Luceco profit-warned the day before the MoneyWeek article on ESO. Also a mention of the stake in Pharmacy2U, whose accounts are well worth a look - they seem to only keep going IMO by endless cash injections, £10m last one I saw, & merging with others.
I'm usually a big fan of heavy discounts, particularly on p/e ITs. Have never, even once, been tempted by ESO - they seem to be mugs, something I concluded when looking into who on earth was pumping more money into Pharmacy2U (who have had a lot of negative comment over their habit of mailshotting the elderly with letters using the NHS logo - nothing illegal, but plenty of comment online about it).
Still - everything has its price I guess, & I know little about the other holdings other than knowing that the NAV discount has come in considerably thanks to LUCE!
From 15th Dec (LUCE closed at 112p yesterday):
"EPE Special Opportunities plc
Net Asset Value
The Directors of EPE Special Opportunities plc ("ESO plc", or the "Company") note the fall in the Luceco plc share price following a trading announcement this morning.
As previously disclosed (including in the full year ESO plc Report and Accounts released 3 April 2017), any change in the Luceco plc share price will impact the ESO plc Net Asset Value.
Should the Luceco plc share price close today at 145.0 pence per ordinary share, the estimated ESO plc fully diluted Net Asset Value will be 315.57 pence per ordinary share.
The end of December 2017 ESO plc fully diluted Net Asset Value will be confirmed in due course. "
Not sure where that leaves the ESO NAV now, but with certain things in it I'd discount completely, and LUCE having gone lower, I can't see ESO as a bargain.
|
23/5/2017
10:41 | horndean eagle: About time the share price responded to nav growth. I can't fathom why the IM has been so tight with the cash. Could have brought a lot more stock back sub 270p. Struggle to see how they are going to deploy all that cash any time soon.
|
15/8/2010
16:17 | jonwig: http://www.epicprivateequity.com/epespecialopportunitiesplc_home.asp
Pending developments here (ie. the RTO of Equity Partnership Investment Company Cap Shares due to be voted on at end-August) suggest that either ESO or EQPC will be a speculative buy.
ESO is acquiring the EQPC portfolio at a discount, but the ESO share price is at a greater discount currently. In any event, the reliance on Whittards, etc. will reduce.
Note the 'incestuous' relationship between the companies.
|
Epe Special Opportunities share price data is direct from the London Stock Exchange
PLUS1
Alliance News Flash Headline